Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System

Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System Original Article, N Engl J Med 2008:358;2457-2467. and Outbreak of Adverse Reactions Associated with Contaminated Heparin Original Article, N Engl J Med 2008:359;2674-2684.. The disclosure statements sh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2010-03, Vol.362 (11), p.1056-1056
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System Original Article, N Engl J Med 2008:358;2457-2467. and Outbreak of Adverse Reactions Associated with Contaminated Heparin Original Article, N Engl J Med 2008:359;2674-2684.. The disclosure statements should have included the following: “Dr. Sasisekharan reports being a named inventor on issued and pending patents concerning the structure and biology of complex glycosaminoglycans.” We regret the errors.
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMx100003